loadpatents
name:-0.018672943115234
name:-0.0078167915344238
name:-0.0054240226745605
Queva; Christophe Patent Filings

Queva; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Queva; Christophe.The latest application filed is for "encapsulated rna polynucleotides and methods of use".

Company Profile
5.6.17
  • Queva; Christophe - Gosselies BE
  • QUEVA; Christophe - Cambridge MA
  • QUEVA; CHRISTOPHE - BAINBRIDGE ISLAND WA
  • Queva; Christophe - Braine L'alleud BE
  • Queva; Christophe - Braine L'Alleud 1420 BE
  • Queva; Christophe - Brainbridge Island WA
  • Queva; Christophe - Waltham MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-TIGIT antibodies
Grant 11,439,705 - Cooper , et al. September 13, 2
2022-09-13
Encapsulated Rna Polynucleotides And Methods Of Use
App 20220117902 - LERNER; Lorena ;   et al.
2022-04-21
Targeted Binding Agents Against B7-h1
App 20210017282 - QUEVA; CHRISTOPHE ;   et al.
2021-01-21
Anti-tigit Antibodies
App 20200407445 - Cooper; Anthony ;   et al.
2020-12-31
Oncolytic Viral Vectors And Uses Thereof
App 20200206285 - FINER; Mitchell H. ;   et al.
2020-07-02
Anti-tigit Antibodies
App 20190315867 - Cooper; Anthony ;   et al.
2019-10-17
Targeted binding agents against B7-H1
Grant 10,400,039 - Queva , et al. Sep
2019-09-03
Anti-TIGIT antibodies
Grant 10,329,349 - Cooper , et al.
2019-06-25
Anti-tigit Antibodies
App 20190100591 - Cooper; Anthony ;   et al.
2019-04-04
Combination Therapies For Treating B-cell Malignancies
App 20180353512 - Collins; Helen ;   et al.
2018-12-13
Combination Therapies For Treating Cancers
App 20180207164 - Abella; Esteban M. ;   et al.
2018-07-26
Targeted Binding Agents Against B7-h1
App 20170137522 - QUEVA; CHRISTOPHE ;   et al.
2017-05-18
Therapies For Treating Cancers
App 20160331754 - Dansey; Roger ;   et al.
2016-11-17
Targeted binding agents against B7-H1
Grant 9,493,565 - Queva , et al. November 15, 2
2016-11-15
Therapies For Treating Myeloproliferative Disorders
App 20160279135 - Lannutti; Brian ;   et al.
2016-09-29
Therapies For Treating Myeloproliferative Disorders
App 20150148345 - Lannutti; Brian ;   et al.
2015-05-28
Targeted Binding Agents Against B7-h1
App 20140356353 - QUEVA; CHRISTOPHE ;   et al.
2014-12-04
Targeted binding agents against B7-H1
Grant 8,779,108 - Queva , et al. July 15, 2
2014-07-15
Targeted Binding Agents Against B7-H1
App 20130034559 - Queva; Christophe ;   et al.
2013-02-07
Antibodies Directed to CD20 and Uses Thereof
App 20110129412 - Gazit-Bornstein; Gadi ;   et al.
2011-06-02
Antibodies directed to CD20 and uses thereof
App 20070014720 - Gazit-Bornstein; Gadi ;   et al.
2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed